Ryo Obata

2.5k total citations · 1 hit paper
117 papers, 1.8k citations indexed

About

Ryo Obata is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Ryo Obata has authored 117 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 99 papers in Ophthalmology, 65 papers in Radiology, Nuclear Medicine and Imaging and 31 papers in Molecular Biology. Recurrent topics in Ryo Obata's work include Retinal Diseases and Treatments (82 papers), Glaucoma and retinal disorders (53 papers) and Retinal Imaging and Analysis (45 papers). Ryo Obata is often cited by papers focused on Retinal Diseases and Treatments (82 papers), Glaucoma and retinal disorders (53 papers) and Retinal Imaging and Analysis (45 papers). Ryo Obata collaborates with scholars based in Japan, Singapore and United States. Ryo Obata's co-authors include Rikuo Machinami, Yasuo Yanagi, Susumu Kusunoki, Atsuro Chiba, Ichiro Kanazawa, Yasuhiro Tamaki, Hidenori Takahashi, Tatsuya Inoue, Yuji Inoue and Takashi Ueta and has published in prestigious journals such as PLoS ONE, Neurology and Scientific Reports.

In The Last Decade

Ryo Obata

107 papers receiving 1.8k citations

Hit Papers

Serum anti‐GQ 1b IgG antibody is associated with ophthalm... 1993 2026 2004 2015 1993 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryo Obata Japan 22 1.0k 730 541 459 353 117 1.8k
Seiyo Harino Japan 25 1.6k 1.6× 1.0k 1.4× 231 0.4× 89 0.2× 318 0.9× 63 2.1k
Takeshi Iwase Japan 26 1.3k 1.3× 971 1.3× 158 0.3× 82 0.2× 541 1.5× 110 1.8k
Yuki Morizane Japan 28 1.5k 1.5× 1.2k 1.6× 288 0.5× 76 0.2× 790 2.2× 111 2.3k
Alexandra Lappas Germany 18 920 0.9× 585 0.8× 138 0.3× 49 0.1× 359 1.0× 55 1.2k
Osamu Sawada Japan 23 1.1k 1.1× 821 1.1× 90 0.2× 71 0.2× 415 1.2× 56 1.5k
Sentaro Kusuhara Japan 21 1.1k 1.1× 720 1.0× 174 0.3× 45 0.1× 320 0.9× 96 1.4k
Kameran Lashkari United States 18 822 0.8× 550 0.8× 71 0.1× 79 0.2× 704 2.0× 59 1.6k
Aristomenis Thanos United States 22 949 0.9× 704 1.0× 92 0.2× 58 0.1× 655 1.9× 66 1.7k
Haicheng She China 15 780 0.7× 351 0.5× 71 0.1× 81 0.2× 629 1.8× 38 1.3k
K V Chalam United States 26 1.6k 1.5× 1.1k 1.5× 84 0.2× 34 0.1× 421 1.2× 106 2.0k

Countries citing papers authored by Ryo Obata

Since Specialization
Citations

This map shows the geographic impact of Ryo Obata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryo Obata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryo Obata more than expected).

Fields of papers citing papers by Ryo Obata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryo Obata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryo Obata. The network helps show where Ryo Obata may publish in the future.

Co-authorship network of co-authors of Ryo Obata

This figure shows the co-authorship network connecting the top 25 collaborators of Ryo Obata. A scholar is included among the top collaborators of Ryo Obata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryo Obata. Ryo Obata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Yamanari, Masahiro, et al.. (2025). Quantification of Hyperreflective Foci in Age-related Macular Degeneration by Polarization-Sensitive OCT. Ophthalmology Science. 5(5). 100792–100792. 1 indexed citations
3.
Obata, Ryo, et al.. (2025). Age‐Associated Transcriptomic and Epigenetic Alterations in Mouse Hippocampus. Aging Cell. 24(11). e70233–e70233.
5.
Azuma, Keiko, et al.. (2024). Association between time to treatment and outcome in branch retinal vein occlusion. International Ophthalmology. 44(1). 353–353. 1 indexed citations
6.
Azuma, Keiko, et al.. (2024). Intravitreal anti-vascular endothelial growth factor and combined photodynamic therapy for pachychoroid neovasculopathy: long-term treatment outcomes. Graefe s Archive for Clinical and Experimental Ophthalmology. 262(6). 1811–1818. 5 indexed citations
7.
Arai, Takahiro, et al.. (2023). Longitudinal anatomical and visual outcome of macular telangiectasia type 2 in Asian patients. Scientific Reports. 13(1). 18954–18954. 2 indexed citations
8.
Suzuki, Takafumi, Ryo Obata, Tatsuya Inoue, et al.. (2022). Intravenous lipo-prostaglandin E1 administration for patients with acute central retinal artery occlusion. BMJ Open Ophthalmology. 7(1). e001014–e001014. 6 indexed citations
9.
Suzuki, Takafumi, Tatsuya Inoue, Nozomi Igarashi, et al.. (2021). Association between serum soluble fms-like tyrosine kinase-1 and the central choroidal thickness during pregnancy: a prospective study. BMJ Open Ophthalmology. 6(1). e000888–e000888. 2 indexed citations
10.
Obata, Ryo, Tatsuya Inoue, Ryo Asaoka, et al.. (2021). Visual outcomes and prognostic factors of vitrectomy for lamellar macular holes and epiretinal membrane foveoschisis. PLoS ONE. 16(2). e0247509–e0247509. 16 indexed citations
11.
Nakahara, Ken‐ichi, Ryo Asaoka, Masaki Tanito, et al.. (2021). Deep learning-assisted (automatic) diagnosis of glaucoma using a smartphone. British Journal of Ophthalmology. 106(4). 587–592. 20 indexed citations
12.
Minami, Takahiro, Masahiro Yamanari, Satoshi Sugiyama, et al.. (2019). Conventional OCT artifacts in the human sclera revealed by polarization-sensitive OCT. Investigative Ophthalmology & Visual Science. 60(9). 1591–1591. 1 indexed citations
13.
Azuma, Keiko, et al.. (2019). Association between visual function and the integrity of residual ellipsoid zone in resolved central serous chorioretinopathy. Scientific Reports. 9(1). 12433–12433. 23 indexed citations
14.
Murata, Hiroshi, et al.. (2017). The relationship between the retinal structure and visual field measured with the microperimetry: MP-3, in patients with retinitis pigmentosa.. Investigative Ophthalmology & Visual Science. 58(8). 3242–3242. 1 indexed citations
15.
Hashimoto, Yohei, Mieko Yanagisawa, Hiroshi Murata, et al.. (2017). The structure-function relationship measured with optical coherence tomography and a microperimeter with auto-tracking: the MP-3, in patients with retinitis pigmentosa. Scientific Reports. 7(1). 15766–15766. 24 indexed citations
16.
Azuma, Keiko, Ryo Obata, Yoko Nomura, et al.. (2016). ANGIOGRAPHIC FINDINGS OF RANIBIZUMAB-RESISTANT POLYPOIDAL CHOROIDAL VASCULOPATHY AFTER SWITCHING TO A TREAT-AND-EXTEND REGIMEN WITH INTRAVITREAL AFLIBERCEPT. Retina. 36(11). 2158–2165. 14 indexed citations
17.
Obata, Ryo, et al.. (2014). Obscuration of the inner choroidal layer in central serous chorioretinopathy. Investigative Ophthalmology & Visual Science. 55(13). 6388–6388. 1 indexed citations
18.
Obata, Ryo, et al.. (2007). Relationship between Intensity of Reflected Light and Temperature Increase: Assessment of Fundus Pigmentation for Transpupillary Thermotherapy. Japanese Journal of Ophthalmology. 51(6). 462–469. 3 indexed citations
19.
Takahashi, Hajime, Ryo Obata, Yasuo Yanagi, et al.. (2006). Influence of Insulin Receptor Substrate–2–Knockout on the Activity of Experimental Choroidal Neovascular in Mice Model. Investigative Ophthalmology & Visual Science. 47(13). 2595–2595. 1 indexed citations
20.
Takahashi, Hidenori, Ryo Obata, & Yasuhiro Tamaki. (2006). A Novel Vascular Endothelial Growth Factor Receptor 2 Inhibitor, SU11248, Suppresses Choroidal Neovascularization In Vivo. Journal of Ocular Pharmacology and Therapeutics. 22(4). 213–218. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026